A protocol to develop clinical guidelines for inclusion-body myositis

Muscle & Nerve
Katherine L JonesIBM Guideline Development Group

Abstract

Inclusion-body myositis (IBM) is a late-onset idiopathic inflammatory myopathy associated with selective and progressive muscle weakness and atrophy. Current clinical management of IBM is largely supportive due to its uncertain etiology and lack of effective treatment. Establishing a consensus of opinion on questions relating to diagnosis and management of IBM is expected to help reduce inconsistencies in the care and resources allocated to those living with this condition. A protocol has been developed to produce best practice clinical guidelines for IBM based on a combination of published research and expert consensus. In this study we describe the proposed protocol for developing methods for producing robust and transparent clinical guidance on aspects of diagnosis, drug treatment, physical and practical management, respiration, nutrition and cardiac management, psychosocial management, and multidisciplinary care.

References

Sep 1, 1995·Journal of Evaluation in Clinical Practice·J GrimshawI Russell
Jun 19, 2007·BMC Medical Informatics and Decision Making·Connie SchardtPaul Fontelo
Sep 1, 2007·Journal of Child Neurology·Ching H WangUNKNOWN Participants of the International Conference on SMA Standard of Care
Sep 26, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Merrilee NeedhamFrank L Mastaglia
Dec 1, 2009·Lancet Neurology·Katharine BushbyUNKNOWN DMD Care Considerations Working Group
Dec 1, 2009·Lancet Neurology·Katharine BushbyUNKNOWN DMD Care Considerations Working Group
Jul 6, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·R SadjadiUNKNOWN Muscle Study Group
Jan 11, 2011·Journal of Clinical Epidemiology·David MoherJohn Hoey
Feb 4, 2011·Rheumatology·Fieke M CoxUmesh A Badrising
Aug 4, 2011·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Anto I BagićUNKNOWN ACMEGS Clinical Practice Guideline (CPG) Committee
Nov 26, 2013·Neuromuscular Disorders : NMD·M R Rose, UNKNOWN ENMC IBM Working Group

❮ Previous
Next ❯

Citations

Jan 12, 2017·Neuropathology and Applied Neurobiology·Y AllenbachW Stenzel
Aug 24, 2017·Current Opinion in Rheumatology·Karsten Schmidt, Jens Schmidt
Aug 24, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Elie NaddafMazen M Dimachkie
Jun 6, 2018·Journal of Neuromuscular Diseases·Jens Schmidt
Dec 16, 2020·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·A BrandUNKNOWN European Mediterranean Initiative for Transfusion Medicine

❮ Previous
Next ❯

Software Mentioned

SurveyMonkey
Critical Appraisal Skills Programme ( CASP )

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medicine and Science in Sports and Exercise
Bruno GualanoCarlos Ugrinowitsch
Journal of Clinical Neuromuscular Disease
P Kaufmann, H Mitsumoto
Revista clínica española
M Villarreal García-Lomas, M Yebra Bango
© 2022 Meta ULC. All rights reserved